Capital Change Notice

Capital Change Notice

Updated as at 17 October 2019


Section 1: Issuer information
Name of issuer Third Age Health Services Limited (the
Company)
NZX ticker code TAH
Class of financial product Ordinary shares
ISIN (If unknown, check on NZX website) NZTAHE0001S0
Currency NZD

Section 2: Capital change details
Number issued/acquired/redeemed 50,000 ordinary shares issued
Nominal value (if any) N/A
Issue/acquisition/redemption price per security $1.5125
Nature of the payment (for example, cash or
other consideration)
Cash
Amount paid up (if not in full) Paid in full.
Percentage of total class of Financial Products
issued/acquired/redeemed/ (calculated on the
number of Financial Products of the Class,
excluding any Treasury Stock, in existence)
1

0.5%
For an issue of Convertible Financial Products
or Options, the principal terms of Conversion
(for example the Conversion price and
Conversion date and the ranking of the Financial
Product in relation to other Classes of Financial
Product) or the Option (for example, the
exercise price and exercise date)
N/A
Reason for issue/acquisition/redemption and
specific authority for
issue/acquisition/redemption/ (the reason for
change must be identified here)
In March 2017, a participant was granted the
options to acquire 50,000 ordinary shares at
an agreed price of $1.5125, based on the
Board’s assessment of the fair value of the
company at the time. The shares have been
held by the Third Age Health Services
Limited Employee Share Purchase Plan
Trust (“Trust") till such time that the
participant paid for them in full.

With the participant now having completed
making full payment for shares the shares
have been issued to the participant.
Total number of Financial Products of the Class
after the
10,001,363 ordinary shares


1
The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Section 2: Capital change details
issue/acquisition/redemption/Conversion
(excluding Treasury Stock) and the total number
of Financial Products of the Class held as
Treasury Stock after the
issue/acquisition/redemption.
No shares remain in the Trust.
In the case of an acquisition of shares, whether
those shares are to be held as treasury stock
N/A
Specific authority for the issue, acquisition, or
redemption, including a reference to the rule
pursuant to which the issue, acquisition, or
redemption is made
The Trustees of the Trust have approved the
transfer of the shares.
Terms or details of the issue, acquisition, or
redemption (for example: restrictions, escrow
arrangements)
N/A
Date of issue/acquisition/redemption
2
8 December 2022
Section 3: Authority for this announcement and contact person
Name of person

authorised to make this
announcement
Tony Wai
Contact person for this announcement Neil Hopkins
Contact phone number 021 760 745
Contact email address neil@thirdagehealth.co.nz
Date of release through MAP

9 December 2022




2
Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant
issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).